Ketoprofen, gel 2.5% 50 g

It has a local anti-inflammatory, anti-exudative and analgesic effect. By inhibiting cyclooxygenase type I and II, inhibits synthesis of prostaglandins. It has anti-bradykinin activity, stabilizes lysosomal membranes and inhibits the release of enzymes that contribute to tissue destruction in chronic inflammation. Ketoprofen, penetrating through the skin, reaches the focus of inflammation, thus providing the possibility of local treatment of lesions (joints, tendons, ligaments and muscles) accompanied by pain syndrome. In case of joint syndrome it relieves pain in joints at rest and when moving, reduces morning stiffness and joint swelling.

Pharmacotherapeutic group
Nonsteroidal anti-inflammatory drug (NSAIDs)

ATC code
M02AA10

Indications

Acute and chronic inflammatory diseases of the musculoskeletal system (articular syndrome with exacerbation of gout, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, osteoarthritis, osteochondrosis with radicular syndrome, radiculitis, inflammatory damage to ligaments and tendons, bursitis, sciatica, lumbago). • Muscle pain of rheumatic and non-rheumatic origin. • Post-traumatic inflammation of soft tissues and the musculoskeletal system (damage and rupture of ligaments, bruises). The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, does not affect the progression of the disease.

Pharmacological effect

It has local anti-inflammatory, anti-exudative and analgesic effects. By inhibiting cyclooxygenase types I and II, it inhibits the synthesis of prostaglandins. It has anti-bradykinin activity, stabilizes lysosomal membranes and delays the release of enzymes that contribute to tissue destruction during chronic inflammation. Ketoprofen, penetrating through the skin, reaches the source of inflammation, thus providing the possibility of local treatment of lesions (joints, tendons, ligaments and muscles) accompanied by pain. In case of articular syndrome, it causes a decrease in pain in the joints at rest and during movement, a decrease in morning stiffness and swelling of the joints.

Pharmacotherapeutic group
Non-steroidal anti-inflammatory drug (NSAID)

ATX code
M02AA10

Active ingredient

Ketoprofen

Composition

100 g of gel contains the active substance: ketoprofen – 2.5 g.

Contraindications

Individual hypersensitivity to ketoprofen or other components of the drug, acetylsalicylic acid or other NSAIDs (history of bronchospasm, urticaria or rhinitis caused by taking acetylsalicylic acid); tiaprofenic acid and fenofibrate; – complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose or paranasal sinuses and intolerance to acetylsalicylic acid and other NSAIDs (including a history); – a history of increased sensitivity of the skin to the effects of solar radiation (photosensitivity); – a history of skin allergies to sunscreens or perfumes; – exposure to the sun on the treated areas, including a solarium during the course of using the drug and 2 weeks after. – weeping dermatoses, eczema, infected abrasions, wounds (at the site of application of the gel); – children under 12 years of age (efficacy and safety have not been studied); – pregnancy (III trimester) and breastfeeding period.

Manufacturer

Ozon, Russia